{"transactions":[{"id":897744,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-18T21:15:20.000Z","date":"2026-02-15","kind":"grant","planned":false,"acquired":true,"shares":4520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2027. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":29144,"source":{"system":"sec-edgar","filing":"0001375124-26-000002","document":"form4-02182026_040209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000137512426000002/form4-02182026_040209.xml","form_type":"4"}},{"id":1261099,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-19T21:37:03.000Z","date":"2025-02-15","kind":"grant","planned":false,"acquired":true,"shares":3298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on February 15, 2026. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":24624,"source":{"system":"sec-edgar","filing":"0001415889-25-004650","document":"form4-02192025_090259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000141588925004650/form4-02192025_090259.xml","form_type":"4"}},{"id":1683058,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-09T21:03:58.000Z","date":"2024-01-05","kind":"grant","planned":false,"acquired":true,"shares":2377,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2025. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":21326,"source":{"system":"sec-edgar","filing":"0001415889-24-000848","document":"form4-01092024_090151.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000141588924000848/form4-01092024_090151.xml","form_type":"4"}},{"id":1783279,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-09-12T18:20:24.000Z","date":"2023-09-09","kind":"exercise","planned":true,"acquired":false,"shares":768133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On August 11, 2022, the reporting person was granted RSUs, of which all 768,133 vested as of September 9, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On August 11, 2022, the reporting person was granted RSUs, of which all 768,133 vested as of September 9, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":768133},"source":{"system":"sec-edgar","filing":"0000899243-23-018762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924323018762/doc4.xml","form_type":"4"}},{"id":1783278,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-12T18:20:24.000Z","date":"2023-09-12","kind":"sale","planned":true,"acquired":false,"shares":410196,"price":0.07,"value":28713.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Pursuant to a binding contract entered into between the issuer and the reporting person on August 15, 2022, this represents the shares automatically sold by the reporting person to satisfy tax withholding obligations in connection with the vesting of the RSUs listed in Table II. Such binding contract is intended to be consistent with the affirmative action defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. This sale does not represent a discretionary trade by the reporting person."}],"balance_after":1175291,"source":{"system":"sec-edgar","filing":"0000899243-23-018762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924323018762/doc4.xml","form_type":"4"}},{"id":1783277,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-12T18:20:24.000Z","date":"2023-09-09","kind":"exercise","planned":true,"acquired":true,"shares":768133,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into Common Stock of the issuer on a one-for-one basis. This transaction represents the settlement of RSUs in shares of Common Stock on their vesting date."}],"balance_after":1585487,"source":{"system":"sec-edgar","filing":"0000899243-23-018762","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924323018762/doc4.xml","form_type":"4"}},{"id":2059144,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-09T21:20:25.000Z","date":"2023-01-05","kind":"grant","acquired":true,"shares":1970,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2024. On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":18949,"source":{"system":"sec-edgar","filing":"0001415889-23-000675","document":"form4-01092023_090110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000141588923000675/form4-01092023_090110.xml","form_type":"4"}},{"id":2437064,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-01-12T17:00:54.000Z","date":"2022-01-11","kind":"grant","acquired":true,"shares":576100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the shares on January 31, 2022 and vests as to 1/48th of the shares at the end of each calendar month thereafter."}],"balance_after":576100,"derivative":{"exercise_price":1.53,"expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":576100},"source":{"system":"sec-edgar","filing":"0001140361-22-001477","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000114036122001477/form4.xml","form_type":"4"}},{"id":2441916,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-06T21:09:10.000Z","date":"2022-01-05","kind":"grant","acquired":true,"shares":1841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2023.  On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":16979,"source":{"system":"sec-edgar","filing":"0001179110-22-000300","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911022000300/edgar.xml","form_type":"4"}},{"id":2913982,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-07T21:14:00.000Z","date":"2021-01-05","kind":"grant","acquired":true,"shares":2302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This grant is represented by Restricted Stock Units (RSU) and will vest in one installment on January 5, 2022.  On the vesting date, each RSU will automatically convert into a similar number of shares of Common Stock."}],"balance_after":15138,"source":{"system":"sec-edgar","filing":"0001179110-21-000399","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911021000399/edgar.xml","form_type":"4"}},{"id":2933397,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-23T16:05:08.000Z","date":"2020-12-22","kind":"grant","acquired":true,"shares":485000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the shares on December 31, 2020 and vests as to 1/48th of the shares at the end of each calendar month thereafter."}],"balance_after":485000,"derivative":{"exercise_price":2.14,"expiration_date":"2030-12-22","underlying":"Common Stock","underlying_shares":485000},"source":{"system":"sec-edgar","filing":"0000899243-20-034968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924320034968/doc4.xml","form_type":"4"}},{"id":3312766,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-01-13T17:00:15.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":606250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 1/48th of the shares on January 31, 2020 and vests as to 1/48th of the shares at the end of each calendar month thereafter."}],"balance_after":606250,"derivative":{"exercise_price":1.25,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":606250},"source":{"system":"sec-edgar","filing":"0000899243-20-001080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924320001080/doc4.xml","form_type":"4"}},{"id":3312765,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-01-13T17:00:15.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":155134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the reporting person's 2019 contingent compensation award paid in shares of common stock in lieu of cash at the election of the Compensation Committee of the issuer's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,593 shares of common stock acquired by the reporting person on June 14, 2019 and 10,593 shares of common stock acquired by the reporting person on December 13, 2019 through participation in the issuer's Employee Stock Purchase Plan."}],"balance_after":793190,"source":{"system":"sec-edgar","filing":"0000899243-20-001080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924320001080/doc4.xml","form_type":"4"}},{"id":3316688,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-07T16:49:38.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":2472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are represented by restricted stock units.  Shares of common stock vest in one installment on January 6, 2021."}],"balance_after":12836,"source":{"system":"sec-edgar","filing":"0001179110-20-000354","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911020000354/edgar.xml","form_type":"4"}},{"id":3489963,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T16:05:26.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":242000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was approved by the Compensation Committee of the Board of Directors of Infinity Pharmaceuticals, Inc., on January 4, 2019, contingent upon shareholder approval of the Company's 2019 Equity Incentive Plan under which the options were granted, which was approved by shareholders on June 13, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter."}],"balance_after":242000,"derivative":{"exercise_price":1.24,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":242000},"source":{"system":"sec-edgar","filing":"0000899243-19-017000","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924319017000/doc4.xml","form_type":"4"}},{"id":3698350,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-10T16:51:03.000Z","date":"2019-01-07","kind":"grant","acquired":true,"shares":4134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are represented by restricted stock units.  Shares of common stock vest in one installment on January 7, 2020."}],"balance_after":10364,"source":{"system":"sec-edgar","filing":"0001179110-19-000640","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911019000640/edgar.xml","form_type":"4"}},{"id":3702183,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-01-07T16:05:31.000Z","date":"2019-01-04","kind":"grant","acquired":true,"shares":243000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/48th of the shares on January 31, 2019 and vests as to 1/48th of the shares at the end of each calendar month thereafter."}],"balance_after":243000,"derivative":{"exercise_price":1.24,"expiration_date":"2029-01-04","underlying":"Common Stock","underlying_shares":243000},"source":{"system":"sec-edgar","filing":"0000899243-19-000653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924319000653/doc4.xml","form_type":"4"}},{"id":3802330,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-10-02T16:30:59.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":5000,"price":2.82,"value":14100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in this line of Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.80 to $2.88, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 7,309 shares of common stock acquired by Ms. Perkins on June 16, 2018 through participation in the issuer's Employee Stock Purchase Plan."}],"balance_after":609561,"source":{"system":"sec-edgar","filing":"0000899243-18-025797","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318025797/doc4.xml","form_type":"4"}},{"id":4008636,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-03-07T16:22:36.000Z","date":"2018-03-05","kind":"sale","acquired":false,"shares":5000,"price":2.778,"value":13890.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The disposition reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 17, 2017."}],"balance_after":607252,"source":{"system":"sec-edgar","filing":"0000899243-18-006636","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318006636/doc4.xml","form_type":"4"}},{"id":4103405,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-09T20:59:12.000Z","date":"2018-01-05","kind":"grant","acquired":true,"shares":3474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are represented by restricted stock units.  Shares of restricted common stock vest in one installment on January 5, 2019."}],"balance_after":6230,"source":{"system":"sec-edgar","filing":"0001179110-18-000729","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911018000729/edgar.xml","form_type":"4"}},{"id":4103396,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-09T16:10:51.000Z","date":"2018-01-08","kind":"grant","acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 50% of the shares on May 25, 2018, and as to the remaining 50% of the shares on May 25, 2019."}],"balance_after":500000,"derivative":{"exercise_price":1.985,"expiration_date":"2028-01-08","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0000899243-18-000796","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318000796/doc4.xml","form_type":"4"}},{"id":4108108,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-01-04T16:06:17.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":180000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests over a period of two years in equal annual installments on the first and second anniversary of the date of grant."}],"balance_after":180000,"derivative":{"exercise_price":2.23,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":180000},"source":{"system":"sec-edgar","filing":"0000899243-18-000458","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318000458/doc4.xml","form_type":"4"}},{"id":4108107,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-01-04T16:06:17.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":69924,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the reporting person's 2017 contingent compensation award paid in shares of common stock in lieu of cash at the election of the Compensation Committee of the issuer's Board of Directors."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,308 shares of common stock acquired by Ms. Perkins on December 15, 2017 through participation in the issuer's Employee Stock Purchase Plan."}],"balance_after":612252,"source":{"system":"sec-edgar","filing":"0000899243-18-000458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924318000458/doc4.xml","form_type":"4"}},{"id":4252682,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-07-24T17:48:56.000Z","date":"2017-07-21","kind":"grant","acquired":true,"shares":85800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested on July 21, 2017."}],"balance_after":535020,"source":{"system":"sec-edgar","filing":"0000899243-17-018767","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924317018767/doc4.xml","form_type":"4"}},{"id":4298327,"issuer":{"id":3609,"kind":"organization","name":"BRUKER CORP","symbol":"BRKR"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-01T18:11:32.000Z","date":"2017-05-31","kind":"grant","acquired":true,"shares":2756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are represented by restricted stock units.  Shares of restricted common stock vest in one installment on the anniversary of the grant date, May 31, 2018."}],"balance_after":2756,"source":{"system":"sec-edgar","filing":"0001179110-17-008299","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1109354/000117911017008299/edgar.xml","form_type":"4"}},{"id":4352072,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-04-14T16:05:28.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":85800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested in full on October 31, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This amendment is being filed to correct the total amount of securities beneficial owned following the reported transaction to reflect 1,809 shares of common stock purchased through the issuer's Employee Stock Purchase Plan on June 30, 2016."}],"balance_after":449220,"source":{"system":"sec-edgar","filing":"0000899243-17-010314","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924317010314/doc4a.xml","form_type":"4/A","original_submission_date":"2016-11-02"}},{"id":4495291,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-09T16:47:25.000Z","date":"2017-01-06","kind":"grant","acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on January 6, 2018."}],"balance_after":1000000,"derivative":{"exercise_price":1.46,"expiration_date":"2027-01-06","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0000899243-17-000806","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924317000806/doc4.xml","form_type":"4"}},{"id":4569569,"issuer":{"id":109802,"kind":"organization","name":"INFINITY PHARMACEUTICALS, INC.","symbol":"INFI"},"owners":[{"id":65961,"kind":"person","name":"Perkins Adelene Q","position":1,"cik":"0001375124","reported_name":"Perkins Adelene Q","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2016-11-02T16:55:45.000Z","date":"2016-10-31","kind":"grant","acquired":true,"shares":85800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares from a grant of performance-based restricted stock on July 22, 2016. Upon the determination by the Compensation Committee of our Board of Directors, such shares vested in full on October 31, 2016."}],"balance_after":447411,"source":{"system":"sec-edgar","filing":"0000899243-16-032620","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1113148/000089924316032620/doc4.xml","form_type":"4"}}]}